470 likes | 588 Views
Making Sense of Health Care Markets - 2006. Presentation to Greater Milwaukee Employee Benefits Council October 16, 2006 Merton D. Finkler, Ph.D Professor of Economics Lawrence University. Overview. The 80-20 rule applies to health care. Good prices need not mean good value.
E N D
Making Sense of Health Care Markets - 2006 Presentation to Greater Milwaukee Employee Benefits Council October 16, 2006 Merton D. Finkler, Ph.D Professor of Economics Lawrence University
Overview • The 80-20 rule applies to health care. • Good prices need not mean good value. • Consumer directed health care can be oversold. • Porter & Teisberg’s competitive ideal can focus our attention: Pay for Performance. • The health care world is not yet flat, but we can flatten it much more than we have.
Key Sources • Agency for Health Care Research and Quality, “The High Concentration of U.S. Health Care Expenditures,” Research in Action, June 2006 • David Cutler, Your Money or Your Life, Oxford Press, 2004 • Michael Porter and Elizabeth Teisberg, “Redefining Competition in Health Care, Harvard Business Review,” June 2004 (and recent book) • Thomas Friedman, The World is Flat, updated and expanded edition, Farrar, Straus, and Giroux, 2006
Your Money or Your Life - Cutler • We spend more because we can do more • 10 fold decline in infant mortality in 20th century • Life expectancy at 45 increased by 4.5 years since 1950 due to reduced mortality from cardiovascular disease • Doubling of costs of treating depression in the last 20 years has yielded improved quality of life and productivity worth 7 times the cost.
Single Biggest Factor in Reduced Mortality is Care for CV Disease
Much Care Does Not Deliver Value • Payment systems (especially fee-for-service) are largely based on intensity not value • Dependent on who delivers the service • Where the service is delivered • Barriers to entry for competitors • Few providers make money by keeping people healthy • Programs that reduce complications in diabetics, and thus, hospitalizations, reduce incomes for physicians and hospitals.
Patients have had little reason to seek value • No information on quality of care differences • Little incentive to seek value since intensive services have been covered by third parties • Just as likely to reduce cost-effective as cost-ineffective services when faced with high out-of-pocket costs. • Current income tax exemptions • Encourage purchase of coverage for high intensity services • Reward people with high incomes for using these services • Thus, current tax policy is both inefficient and inequitable
Episodic acute and chronic care Heroic interventions (surgeries, tests, …) Value and Waste - Overall Value of Services Low High Health promotion (Follow-up/monitoring) Intensity of Services Chronic disease management High Low
Value and Waste – Traditional Payment Value of Services Low High Follow up/monitoring Intensity of Services High Low Disease management Fancy Stuff
Waste and Value – Managed Care Value of Services Low High Follow up/monitoring Intensity of Services High Low Disease management Fancy Stuff
Waste and Value – Pay for Quality Value of Services Low High Follow up/monitoring Intensity of Services High Low Disease management Fancy Stuff
Pay for Performance • Reward high value (quality per unit cost) services by • Measuring and publishing information on quality of medical care • Rewarding providers who deliver value • Offering lower patient cost-sharing for cost-effective care • Covering compliance with chronic care management plans (including RX use)
P4P (Continued) • Will pay for performance be widely adopted? • Over 100 current experiments exist • Bridges to Excellence • Leapfrog • Center for Medicare and Medicaid Services
Consumer Directed Health Care • CDHC responds to the OPM problem: • Aim: reduce entitlement mentality • Standard Features • High deductible insurance plan • Personal account funded partly or fully by employer • Gap between deposited amount and the deductible • Tax system encouragement • Internet-based decision support • Key assumptions • A large percentage of medical care use is discretionary • Out-of-pocket incentives will reduce inappropriate spending
Do Consumers Have the Tools to Make Informed Healthcare Decisions? • 80% of adults w/ internet access seek healthcare information online. • AHRQ’s “Quality Tools” (www.qualitytools.ahrq.gov) • Will consumers distinguish between accurate and false (or irrelevant) information? • Recent Rand study: only 27% of consumers use formal sources of information to choose a physician • Health Insurance Experiment showed that increased cost-sharing yielded reduced use of both effective and ineffective services
CDHC (Continued) • Quality of service information (patient satisfaction) is available in a number of markets. • Study of elderly suggests no correlation between consumer satisfaction survey results and expert measures of the quality of care provided. • Do you know your risk for Cancer? Diabetes? Heart Disease? Osteoporosis? Stoke? If not, check out www.yourdiseaserisk.harvard.edu
CDHC (Continued) • Most likely targets for CHDC are the bottom 50%. • Those in the top 20% typically spend > deductible and face limited incentives to purchase high value/low intensity care & to avoid low value/high intensity care. • Since treated prevalence has increased, incentives to cut back on medical care may be misdirected unless they encourage • Behavior that reduces health risks • Primary and secondary prevention • Compliance with best practice
Angus Deaton’s Story • Economist at Princeton • Advised to obtain a hip replacement • 150,000 done each year • Average cost $50,000 • Only information on orthopedists was the general rule: “go where the volume is.” • No information on prices – of which there are many • Actual transactions prices (and consumer out-of-pockets) were impossible to know in advance. Nor was he asked if he wanted service x at price y. • Result: impossible to know the total cost in advance. • Conclusion: informed consumer decision-making is not trivial
Porter and Teisberg’s competitive ideal for health care • Claim: wrong kind of competition exists – • To shift costs • To increase bargaining power • To capture patients and restrict choice • To restrict services to reduce costs • Right kind of competition • Focuses on value delivered to patients • Based on unlimited competition among providers • Competition base: episode of care for particular medical conditions • Result should be regional & national competition based on who can deliver the most value for patients with particular medical conditions
P and T on Role of Health Plans • Get out of the “denial” business • Provide information to support patient and physician decision-making • Reward excellence and value-enhancement for patients • Simplify administrative structure and billing • Encourage multi-year contracting
P and T on Role of Employers • Increase benefits that add the most health per $ spent instead of seeking to minimize cost • Support enrollees in making cost-effective long term health care choices & in managing their own health • Hold all stakeholders accountable for using benefit dollars wisely
P and T’s Ideal • “Buy value” is not new. At least 20 years old. • Reinhardt: “Porter and Teisberg …offer a utopian vision of a health system that might occur to anyone possessed with a modicum of common sense but not too familiar with the real world of health care.” • See recent Health Affairs blog for reaction: www.healthaffairs.org/blog
A Few Pertinent Questions • Will P and T’s competition decrease the attractiveness of integrated delivery programs and, thus, further fragments delivery structure along new lines – episode of care products? (Enthoven’s says yes) • Will we find a way to agree on appropriate quality measures and deliver such information in cost-effective ways to those who need the information? P4P helps! • Will stakeholders in the current payment structure give up their advantages to benefit the “greater good”? Wishful thinking
The Skeptics • Reinhardt: “It is naïve to assume that the potential losers … would simply roll over and accept their fate.” • Maynard: “…improved control of expenditures … would oblige physicians, nurses, hospitals, and the Rx industry to moderate their lifestyles.”
The health care world is not yet flat, but we can flatten it • The World is Flat – Thomas L. Friedman • Rule No. 1 – Sept 22, 2006 – NY Times • “Whatever can be done, will be done- because so many people now have access to the tools of innovation and connectivity. The only question is: Will it be done by you or to you?” • A Flat World has no barriers to competition: Consumers will seek value and make purchases based on who can deliver it no matter where that provider is located.
Today’s health care world is not flat • Lots of information is available and easily transferable because of online connectivity, but the knowledge to use it is very specialized. • Many barriers to the purchase of such care exist • Travel cost • Lack of Information • Health plan limitations • Poor incentives to seek value
Flatness requires changes in behavior • What are your priorities? Will you go as far to obtain medical care as you would for • A Packers’ Game • To buy a new car • To shop for a suit or dress ? • A change in incentives would help, but information about quality differences matters too. • P and T are right about regionalization of tertiary care. We have too many low volume providers of intensive services. • Leapfrog members have vowed to reward volume since volume is strongly related to cost-effectiveness. • Sacrifices of local access to obtain more cost-effective care
Some services might be ready for flattening: consider radiology • Patient – Physician relationship does not exist • Services can be separated from other aspects of care management • Digital radiography reduces barriers to entry • Does it really matter whether a CT scan or an MRI is read by a Chinese radiologist in Milwaukee, a Greek radiologist in Kansas City or an Indian in Bangalore if the perceived quality is the same? • Does the price differ? Indeed!
What can purchasers do? • Educate people about value • Nexium vs. Prilosec • (United Health Care – won’t cover Nexium) • Give incentives to comply with evidence-based, best practice, especially for those with chronic disease • Chronic care improvement model • http://www.improvingchroniccare.org/ • Design payment structures to • Encourage people to be healthy and to comply with best practices (cost-effective care) • Discourage third party payment for cost-ineffective care
Summary • The rise in health care costs will continue. Technology and demographics will propel it. • Oscar Wilde said “Economists know the price of everything and the value of nothing” • Cutler, Thorpe, Porter, Reinhardt, and Maynard beg to differ! So do I.
Summary (Continued) • To obtain the most for our health care $, public policy needs to stop rewarding high cost/ low value care. • If consumers / patients wish lower spending on health care, they must • accept reduced convenience for some services • reduce their risk of disease • learn to manage the diseases they have • and learn to purchase care that adds value and to not purchase high cost / low value care.
Thank Youfor Your Attentionemail: merton.d.finkler@lawrence.edu